2007
Electrocardiographic manifestations in a hypothermic patient: review of Osborn waves.
Yaganti V, Naik C, Dhond A. Electrocardiographic manifestations in a hypothermic patient: review of Osborn waves. Indian Heart Journal 2007, 59: 80-2. PMID: 19098341.Peer-Reviewed Case Reports and Technical Notes
2006
Repeated Serum Lipid Measurements During the Peri-Hospitalization Period
Nawaz H, Comerford BP, Njike VY, Dhond AJ, Plavec M, Katz DL. Repeated Serum Lipid Measurements During the Peri-Hospitalization Period. The American Journal Of Cardiology 2006, 98: 1379-1382. PMID: 17134633, DOI: 10.1016/j.amjcard.2006.06.030.Peer-Reviewed Original ResearchConceptsHigh-density lipoproteinLow-density lipoproteinTotal cholesterol/HDL ratioCholesterol/HDL ratioTotal cholesterolLipid profile measurementsHDL ratioTreatment decisionsAcute care community hospitalSerum lipid measurementsSerum lipid valuesEarly treatment decisionsHospital stayAcute illnessHospitalized patientsProspective studyCommunity hospitalEarly treatmentLipid measurementsLipid valuesDay 3Treatment categoriesPatientsCholesterolTreatment implications
2003
Anticoagulation in the Elderly
Dhond AJ, Michelena HI, Ezekowitz MD. Anticoagulation in the Elderly. The American Journal Of Geriatric Cardiology 2003, 12: 243-250. PMID: 12888705, DOI: 10.1111/j.1076-7460.2003.02010.x.Peer-Reviewed Original ResearchFactors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: A cross-sectional survey
Gross CP, Vogel EW, Dhond AJ, Marple CB, Edwards RA, Hauch O, Demers EA, Ezekowitz M. Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: A cross-sectional survey. Clinical Therapeutics 2003, 25: 1750-1764. PMID: 12860496, DOI: 10.1016/s0149-2918(03)80167-4.Peer-Reviewed Original ResearchConceptsNonvalvular atrial fibrillationCerebrovascular accidentAtrial fibrillationPhysicians' attitudesBenefits of warfarinMajor bleeding episodesUse of warfarinEmbolic cerebrovascular accidentAmerican Medical Association MasterfileMultivariate logistic regressionCross-sectional studyHigher risk estimatesCross-sectional surveyCase vignettesWarfarin useAnticoagulation therapyBleeding episodesElderly patientsWarfarin therapyComorbid conditionsIntracerebral hemorrhageRisk factorsTreatment recommendationsPhysician ageMedian numberTissue factor pathway inhibitors as a novel approach to antithrombotic therapy.
Sajadi S, Ezekowitz MD, Dhond A, Netrebko P. Tissue factor pathway inhibitors as a novel approach to antithrombotic therapy. Drug News & Perspectives 2003, 16: 363-9. PMID: 12973447, DOI: 10.1358/dnp.2003.16.6.829308.Peer-Reviewed Original ResearchConceptsTissue factor pathway inhibitorFactor pathway inhibitorTissue factorPathway inhibitorNew antithrombotic approachComplications of atherosclerosisPathogenesis of atherosclerosisAntithrombotic therapyAntithrombotic approachEndothelial injurySystemic hemostasisNeointimal formationVascular interventionsAtherosclerotic plaquesEndothelial cellsInhibitory effectExtrinsic pathwayAtherosclerosisInhibitorsPlaquesCoagulationEarly stagesComplicationsFactorsAnticoagulants
2002
Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering
George SJ, Dhond AJ, Alderson SM, Ezekowitz MD. Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering. The American Journal Of Cardiology 2002, 90: 1237-1239. PMID: 12450605, DOI: 10.1016/s0002-9149(02)02841-2.Peer-Reviewed Original Research